Access to telehealth services for colorectal cancer patients in the United States during the COVID-19 pandemic - 08/11/22
Abstract |
Background |
The COVID-19 pandemic yielded rapid telehealth deployment to improve healthcare access, including for surgical patients.
Methods |
We conducted a secret shopper study to assess telehealth availability for new patient and follow-up colorectal cancer care visits in a random national sample of Commission on Cancer accredited hospitals and investigated predictive facility-level factors.
Results |
Of 397 hospitals, 302 (76%) offered telehealth for colorectal cancer patients (75% for follow-up, 42% for new patients). For new patients, NCI-designated Cancer Programs offered telehealth more frequently than Integrated Network (OR: 0.20, p = 0.01), Academic Comprehensive (OR: 0.18, p = 0.001), Comprehensive Community (OR: 0.10, p < 0.001), and Community (OR: 0.11, p < 0.001) Cancer Programs. For follow-up, above average timeliness of care hospitals offered telehealth more frequently than average hospitals (OR: 2.87, p = 0.04).
Conclusions |
We identified access disparities and predictive factors for telehealth availability for colorectal cancer care during the COVID-19 pandemic. These factors should be considered when constructing telehealth policies.
Le texte complet de cet article est disponible en PDF.Highlights |
• | Telehealth use increased during the COVID-19 pandemic to improve healthcare access. |
• | Telehealth was less available to new versus established colorectal cancer patients. |
• | Availability of new patient telehealth visits was predicted by cancer program type. |
• | Follow-up telehealth visits were offered more at hospitals with timely care. |
• | Telehealth access disparities for colorectal cancer care persisted during COVID-19. |
Keywords : Colorectal cancer, Telehealth, Healthcare access, COVID-19 pandemic
Plan
Vol 224 - N° 5
P. 1267-1273 - novembre 2022 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.